Home
David Lamond, Director: Quince Therapeutics QNCX Buy · Filed 23/08/17
Trade details
- Type
- Insider buy
- Amount
- $151,378.92
- Shares · price
- 117,348 sh · $1.29 a share
- Held after
- 2,072,343 sh
- Person
- David LamondDirector
- Trade date
- 23/08/16
- Filed
- 23/08/17
- Days to filing
- 1 days
2 insiders bought this week
- Insiders buying this week
- 2 insiders
- Holding change
- +6.0%
Quince Therapeutics trades, last 26 weeks
What else happened in Quince Therapeutics around then
Filed or reported within 30 days of the trade day · 23/07/17~23/09/15David Lamond's recent trades
- David Lamond
BuyQuince Therapeutics
BuyQuince Therapeutics
QNCX
$23.5K
22,627 sh
$23.5K
Filed 23/12/14
Traded 23/12/14
- David Lamond
BuyQuince Therapeutics
BuyQuince Therapeutics
QNCX
$22.8K
22,327 sh
$22.8K
Filed 23/12/14
Traded 23/12/12
- David Lamond
BuyQuince Therapeutics
BuyQuince Therapeutics
QNCX
$22.6K
22,627 sh
$22.6K
Filed 23/12/14
Traded 23/12/13
- David Lamond
BuyQuince Therapeutics
BuyQuince Therapeutics
QNCX
$300
300 sh
$300
Filed 23/12/14
Traded 23/12/12
- David Lamond
BuyQuince Therapeutics
BuyQuince Therapeutics
QNCX
$19.5K
19,123 sh
$19.5K
Filed 23/12/07
Traded 23/12/06